Drug-Eluting Stents Pose No Greater Risk: Study

Law360, New York (November 5, 2007, 12:00 AM EST) -- Patients who received drug-eluting stents are no more likely to die or suffer a heart attack than those who receive bare-metal versions, according to a recent U.S. study, the latest development in the debate over the safety of the artery-opening devices.

The study, called the Massachusetts stent trial, compared death rates of patients who received drug-eluting stents to those who received bare metal stents between April 1, 2003 and Dec. 31, 2004, and found the drug-coated stents did not result in an increased rate of death...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.